CancerCare is a leading national organization dedicated to providing free support services and financial assistance to anyone affected by cancer. 800-813-HOPE
New York, New York
- Tweets 7,861
- Following 1,623
- Followers 20,713
- Likes 2,502
Pinned Tweet
Last year, @CancerCare provided 150,508 services to people diagnosed with cancer, caregivers and bereaved individuals. Our emotional, practical and financial support programs continued to offer help and hope to anyone affected by cancer.
Learn more at cancercare.org.
2
1
6
897
Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL @EliLillyandCo
investor.lilly.com/news-rele…
215
CancerCare retweeted
“A discount this big shouldn’t be a mystery.” A new @CancerCare & @PioneerPolicy study of nearly 4,000 hospitals finds that #340B hospitals spend less on charity care than hospitals that don’t participate in the program. This research reinforces the need for greater transparency in 340B to ensure the program serves patients. Read more: cancercare.org/press/release…
4
3
167
Join our partners @_KNOW_ALL this Wednesday for a free webinar on support for older adults living with ALL.
Register here: webinar.know-alleukemia.com/…
Save the date!
Wednesday, September 30 | 16:00 (BST)
Join the Know ALL patient webinar on Wednesday, September 30, for a conversation about personalized treatment, wellbeing, and support for older adults living with acute lymphoblastic leukemia.
Register via the link in our comment below.
201
CancerCare retweeted
New study I co-authored, released by @PioneerPolicy and @CancerCare : 340B hospitals spent 2.16% of operating expenses on charity care vs. 2.82% at non-340B hospitals.
Patients deserve accountability.
pioneerinstitute.org/who-ben…
2
2
123
CancerCare retweeted
🚨BREAKING @FDA News🚨
The FDA has approved belzutifan plus lenvatinib for the treatment of patients with advanced renal cell carcinoma with a clear cell component following treatment with PD-1 or PD-L1 inhibitor.
Full details here ➡️: onclive.com/view/fda-approve…
#kcsm #oncology
1
1
6
2,459
CancerCare retweeted
Today, the FDA approved a treatment for advanced renal cell carcinoma. fda.gov/drugs/resources-info…
4
12
49
8,731
FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma
fda.gov/drugs/resources-info…
172
It’s here! Today is World ALL Day!
On this day, we come together as a global community to raise awareness of acute lymphoblastic leukemia (ALL) and stand with every patient, caregiver & family affected.
Join the global campaign: know-alleukemia.com/world-al…
@_KNOW_ALL
#KnowALL
1
1
211
CancerCare retweeted
Today, we approved a treatment for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. This approval gives some people with advanced breast cancer whose tumors have a specific genetic mutation another treatment option. fda.gov/drugs/resources-info…
4
21
41
7,676
CancerCare retweeted
Save the date!
Wednesday, September 30 | 16:00 (BST)
Join the Know ALL patient webinar on Wednesday, September 30, for a conversation about personalized treatment, wellbeing, and support for older adults living with acute lymphoblastic leukemia.
Register via the link in our comment below.
1
1
1
284
This #ThyroidCancerAwarenessMonth, hear how thyroid cancer (TC) survivor Becky and her husband, Michael, navigated the changes that came from her treatment and discovered a recipe they continue to enjoy today. Watch Becky’s story and try her recipe: bit.ly/4d1jIYc
#ad
1
1
206
CancerCare retweeted
Today, we granted accelerated approval to a treatment for locally advanced or metastatic non-squamous non-small cell lung cancer. fda.gov/drugs/resources-info…
ALT A person in a blue shirt holds a white ribbon, symbolizing lung cancer awareness. Text on the image reads: "FDA grants accelerated approval to a treatment for non-small cell lung cancer." The FDA logo is visible in the corner.
2
10
37
6,209
FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1-Mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer
fda.gov/drugs/resources-info…
1
237
If you are a head and neck cancer patient or caregiver, or know someone who may be interested in participating, we encourage you to complete and share the survey using the link below: loom.ly/goj17Ts
1
2
329
FDA approved daraxonrasib (RASONQUE, Revolution Medicines, Inc.), an inhibitor of the RAS GTPase family, for adults with metastatic pancreatic adenocarcinoma
fda.gov/news-events/press-an…
1
199
CancerCare retweeted
Today we approved a first-in-class targeted therapy for metastatic pancreatic cancer – one of the hardest cancers to treat. Today’s approval provides a critical new treatment for patients who’ve had very few options. fda.gov/news-events/press-an…
14
85
260
52,327
Food and Drug Administration approved zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals)
investor.jazzpharma.com/news…
312
CancerCare retweeted
NEWS: FDA approves a treatment for gastric, gastroesophageal junction, or esophageal adenocarcinoma. fda.gov/drugs/resources-info…
ALT A person wearing a purple shirt with a purple ribbon pinned on it stands with arms crossed. The background features the FDA logo in the top right corner. Text on the image reads: "FDA approves a treatment for gastric, gastroesophageal junction, or esophageal adenocarcinoma.
3
13
27
5,834
CancerCare retweeted
🚨BREAKING🚨: @FDA has granted accelerated approval to iberdomide plus daratumumab and hyaluronidase-fihj and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.
Read more here ➡️: onclive.com/view/fda-approve…
#mmsm #oncology
3
11
17
2,117
#FeelGoodFriday 👨👩👧👦NNJCF announces its DeAnna Stark Pasciuto Memorial Fund awarded a grant of $5,000 to @CancerCare in Paramus.
▶Learn more about NNJCF's #donoradvisedfund services & how you can establish one or support an existing one: nnjcf.org/donor-services/est…
#NNJCF #cancer
1
1
58